Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 349 entries
Sorted by: Best Match Show Resources per page
Exploring the Potentials of .

Frontiers in microbiology

Naureen Z, Rehman NU, Hussain H, Hussain J, Gilani SA, Al Housni SK, Mabood F, Khan AL, Farooq S, Abbas G, Harrasi AA.
PMID: 28861045
Front Microbiol. 2017 Aug 17;8:1477. doi: 10.3389/fmicb.2017.01477. eCollection 2017.

There is an ongoing hunt for biologically active compounds that can combat phytopathogenic fungi and improve plant growth without causing any hazards to the environment. Consequently the present study aims at deciphering the plant growth promotion and antifungal capability...

Cite
Naureen Z, Rehman NU, Hussain H, et al. Exploring the Potentials of . Front Microbiol. 2017;8:1477doi: 10.3389/fmicb.2017.01477.
Naureen, Z., Rehman, N. U., Hussain, H., Hussain, J., Gilani, S. A., Al Housni, S. K., Mabood, F., Khan, A. L., Farooq, S., Abbas, G., & Harrasi, A. A. (2017). Exploring the Potentials of . Frontiers in microbiology, 81477. https://doi.org/10.3389/fmicb.2017.01477
Naureen, Zakira, et al. "Exploring the Potentials of ." Frontiers in microbiology vol. 8 (2017): 1477. doi: https://doi.org/10.3389/fmicb.2017.01477
Naureen Z, Rehman NU, Hussain H, Hussain J, Gilani SA, Al Housni SK, Mabood F, Khan AL, Farooq S, Abbas G, Harrasi AA. Exploring the Potentials of . Front Microbiol. 2017 Aug 17;8:1477. doi: 10.3389/fmicb.2017.01477. eCollection 2017. PMID: 28861045; PMCID: PMC5563071.
Copy Download .nbib Format: NLM
Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?.

OncoTargets and therapy

Kus T, Aktas G, Sevinc A, Kalender ME, Camci C.
PMID: 26150726
Onco Targets Ther. 2015 Jun 05;8:1341-3. doi: 10.2147/OTT.S84480. eCollection 2015.

Erlotinib, an epidermal growth factor receptor and tyrosine kinase inhibitor, is a targeted drug that was approved for the treatment of non-small-cell lung cancers and pancreatic cancers. Targeted tyrosine kinase inhibitors are known to have cardiotoxic effects. However, erlotinib...

Cite
Kus T, Aktas G, Sevinc A, et al. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. Onco Targets Ther. 2015;8:1341-3doi: 10.2147/OTT.S84480.
Kus, T., Aktas, G., Sevinc, A., Kalender, M. E., & Camci, C. (2015). Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. OncoTargets and therapy, 81341-3. https://doi.org/10.2147/OTT.S84480
Kus, Tulay, et al. "Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?." OncoTargets and therapy vol. 8 (2015): 1341-3. doi: https://doi.org/10.2147/OTT.S84480
Kus T, Aktas G, Sevinc A, Kalender ME, Camci C. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?. Onco Targets Ther. 2015 Jun 05;8:1341-3. doi: 10.2147/OTT.S84480. eCollection 2015. PMID: 26150726; PMCID: PMC4485179.
Copy Download .nbib Format: NLM
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Reid MD, Bagci P, Ohike N, Saka B, Erbarut Seven I, Dursun N, Balci S, Gucer H, Jang KT, Tajiri T, Basturk O, Kong SY, Goodman M, Akkas G, Adsay V.
PMID: 26715065
Mod Pathol. 2016 Jan;29(1):93. doi: 10.1038/modpathol.2015.124.

No abstract available.

Cite
Reid MD, Bagci P, Ohike N, et al. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol. 2016;29(1):93doi: 10.1038/modpathol.2015.124.
Reid, M. D., Bagci, P., Ohike, N., Saka, B., Erbarut Seven, I., Dursun, N., Balci, S., Gucer, H., Jang, K. T., Tajiri, T., Basturk, O., Kong, S. Y., Goodman, M., Akkas, G., & Adsay, V. (2016). Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 29(1), 93. https://doi.org/10.1038/modpathol.2015.124
Reid, Michelle D, et al. "Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 29,1 (2016): 93. doi: https://doi.org/10.1038/modpathol.2015.124
Reid MD, Bagci P, Ohike N, Saka B, Erbarut Seven I, Dursun N, Balci S, Gucer H, Jang KT, Tajiri T, Basturk O, Kong SY, Goodman M, Akkas G, Adsay V. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol. 2016 Jan;29(1):93. doi: 10.1038/modpathol.2015.124. PMID: 26715065.
Copy Download .nbib Format: NLM
Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.

Molecular and clinical oncology

Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C.
PMID: 26893877
Mol Clin Oncol. 2016 Feb;4(2):290-292. doi: 10.3892/mco.2015.677. Epub 2015 Nov 13.

Hepatocellular carcinoma (HCC) and renal cell cancer (RCC) are malignancies, which are chemotherapy resistant and fatal at the advanced stages. Previously developed tyrosine kinase inhibitors are used in the treatment of advanced stage disease. In the present case study,...

Cite
Kus T, Aktas G, Sevinc A, et al. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer. Mol Clin Oncol. 2015;4(2):290-292doi: 10.3892/mco.2015.677.
Kus, T., Aktas, G., Sevinc, A., Oktay, C., Kalender, M. E., & Camci, C. (2016). Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer. Molecular and clinical oncology, 4(2), 290-292. https://doi.org/10.3892/mco.2015.677
Kus, Tulay, et al. "Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer." Molecular and clinical oncology vol. 4,2 (2016): 290-292. doi: https://doi.org/10.3892/mco.2015.677
Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer. Mol Clin Oncol. 2016 Feb;4(2):290-292. doi: 10.3892/mco.2015.677. Epub 2015 Nov 13. PMID: 26893877; PMCID: PMC4734193.
Copy Download .nbib Format: NLM
The evaluation of red cell distribution width in chronic hemodialysis patients.

International journal of nephrology

Tekce H, Kin Tekce B, Aktas G, Tanrisev M, Sit M.
PMID: 24800077
Int J Nephrol. 2014;2014:754370. doi: 10.1155/2014/754370. Epub 2014 Mar 30.

Background. Red cell distribution width (RDW) has been used as a marker of iron deficiency; however, it is accepted as a marker of cardiovascular survival. We aimed to study RDW levels in hemodialysis (HD) patients and the association between...

Cite
Tekce H, Kin Tekce B, Aktas G, et al. The evaluation of red cell distribution width in chronic hemodialysis patients. Int J Nephrol. 2014;2014:754370doi: 10.1155/2014/754370.
Tekce, H., Kin Tekce, B., Aktas, G., Tanrisev, M., & Sit, M. (2014). The evaluation of red cell distribution width in chronic hemodialysis patients. International journal of nephrology, 2014754370. https://doi.org/10.1155/2014/754370
Tekce, Hikmet, et al. "The evaluation of red cell distribution width in chronic hemodialysis patients." International journal of nephrology vol. 2014 (2014): 754370. doi: https://doi.org/10.1155/2014/754370
Tekce H, Kin Tekce B, Aktas G, Tanrisev M, Sit M. The evaluation of red cell distribution width in chronic hemodialysis patients. Int J Nephrol. 2014;2014:754370. doi: 10.1155/2014/754370. Epub 2014 Mar 30. PMID: 24800077; PMCID: PMC3988915.
Copy Download .nbib Format: NLM
Serum sodium levels in sigmoid volvulus.

The Eurasian journal of medicine

Atamanalp SS, Keles MS, Ozturk G, Ozogul B, Kısaoglu A, Akbas A.
PMID: 25610055
Eurasian J Med. 2009 Apr;41(1):1-3.

OBJECTIVE: Sigmoid volvulus (SV) is an uncommon type of large bowel obstruction. This study sought to determine serum sodium concentrations in patients with SV.MATERIALS AND METHODS: The records of 89 patients with SV and 40 patients with obstructive rectosigmoid...

Cite
Atamanalp SS, Keles MS, Ozturk G, et al. Serum sodium levels in sigmoid volvulus. Eurasian J Med. 2009;41(1):1-3
Atamanalp, S. S., Keles, M. S., Ozturk, G., Ozogul, B., Kısaoglu, A., & Akbas, A. (2009). Serum sodium levels in sigmoid volvulus. The Eurasian journal of medicine, 41(1), 1-3.
Atamanalp, S Selcuk, et al. "Serum sodium levels in sigmoid volvulus." The Eurasian journal of medicine vol. 41,1 (2009): 1-3.
Atamanalp SS, Keles MS, Ozturk G, Ozogul B, Kısaoglu A, Akbas A. Serum sodium levels in sigmoid volvulus. Eurasian J Med. 2009 Apr;41(1):1-3. PMID: 25610055; PMCID: PMC4261657.
Copy Download .nbib Format: NLM
Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation.

Prostate cancer and prostatic diseases

Türkeri LN, Ayaz O, Ozyürek M, Akdas A.
PMID: 12496812
Prostate Cancer Prostatic Dis. 1999 Nov;2:S33. doi: 10.1038/sj.pcan.4500358.

No abstract available.

Cite
Türkeri LN, Ayaz O, Ozyürek M, et al. Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation. Prostate Cancer Prostatic Dis. 1999;2:S33doi: 10.1038/sj.pcan.4500358.
Türkeri, L. N., Ayaz, O., Ozyürek, M., & Akdas, A. (1999). Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation. Prostate cancer and prostatic diseases, 2S33. https://doi.org/10.1038/sj.pcan.4500358
Türkeri, L N, et al. "Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation." Prostate cancer and prostatic diseases vol. 2 (1999): S33. doi: https://doi.org/10.1038/sj.pcan.4500358
Türkeri LN, Ayaz O, Ozyürek M, Akdas A. Augmented cytotoxicity of estramustine and etoposide combination in hormone refractory prostate cancer cell lines and association with TGF modulation. Prostate Cancer Prostatic Dis. 1999 Nov;2:S33. doi: 10.1038/sj.pcan.4500358. PMID: 12496812.
Copy Download .nbib Format: NLM
Comparison of arteriovenous fistula recirculation by thermodilution and urea - based method.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Rafique Z, Abbas G, Shafi T.
PMID: 17999850
J Coll Physicians Surg Pak. 2007 Oct;17(10):603-6. doi: 10.2007/JCPSP.603606.

OBJECTIVE: To compare arteriovenous fistula recirculation by thermodilution technique and urea based two needle slow flow method.DESIGN: Comparative cross-sectional study.PLACE AND DURATION OF STUDY: Hemodialysis Unit of Nephrology Department of Shaikh Zayed Hospital, Lahore, from October 2005 to December...

Cite
Rafique Z, Abbas G, Shafi T. Comparison of arteriovenous fistula recirculation by thermodilution and urea - based method. J Coll Physicians Surg Pak. 2007;17(10):603-6doi: 10.2007/JCPSP.603606.
Rafique, Z., Abbas, G., & Shafi, T. (2007). Comparison of arteriovenous fistula recirculation by thermodilution and urea - based method. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 17(10), 603-6. https://doi.org/10.2007/JCPSP.603606
Rafique, Zahid, et al. "Comparison of arteriovenous fistula recirculation by thermodilution and urea - based method." Journal of the College of Physicians and Surgeons--Pakistan : JCPSP vol. 17,10 (2007): 603-6. doi: https://doi.org/10.2007/JCPSP.603606
Rafique Z, Abbas G, Shafi T. Comparison of arteriovenous fistula recirculation by thermodilution and urea - based method. J Coll Physicians Surg Pak. 2007 Oct;17(10):603-6. doi: 10.2007/JCPSP.603606. PMID: 17999850.
Copy Download .nbib Format: NLM
Magnetic and 57Fe Mössbauer study of the single molecule magnet behavior of a Dy3Fe7 coordination cluster.

Inorganic chemistry

Abbas G, Lan Y, Mereacre V, Wernsdorfer W, Clérac R, Buth G, Sougrati MT, Grandjean F, Long GJ, Anson CE, Powell AK.
PMID: 19711941
Inorg Chem. 2009 Oct 05;48(19):9345-55. doi: 10.1021/ic901248r.

The reaction between N-methydiethanolamine (mdeaH(2)), benzoic acid, FeCl(3), and DyCl(3) yields a decanuclear coordination cluster, [Dy(3)Fe(7)(mu(4)-O)(2)(mu(3)-OH)(2)(mdea)(7)(mu-benzoate)(4)(N(3))(6)] x 2 H(2)O x 7 CH(3)OH (1) whose single crystal structure exhibits three and seven crystallographically distinct Dy(III) and Fe(III) ions; six of...

Cite
Abbas G, Lan Y, Mereacre V, et al. Magnetic and 57Fe Mössbauer study of the single molecule magnet behavior of a Dy3Fe7 coordination cluster. Inorg Chem. 2009;48(19):9345-55doi: 10.1021/ic901248r.
Abbas, G., Lan, Y., Mereacre, V., Wernsdorfer, W., Clérac, R., Buth, G., Sougrati, M. T., Grandjean, F., Long, G. J., Anson, C. E., & Powell, A. K. (2009). Magnetic and 57Fe Mössbauer study of the single molecule magnet behavior of a Dy3Fe7 coordination cluster. Inorganic chemistry, 48(19), 9345-55. https://doi.org/10.1021/ic901248r
Abbas, Ghulam, et al. "Magnetic and 57Fe Mössbauer study of the single molecule magnet behavior of a Dy3Fe7 coordination cluster." Inorganic chemistry vol. 48,19 (2009): 9345-55. doi: https://doi.org/10.1021/ic901248r
Abbas G, Lan Y, Mereacre V, Wernsdorfer W, Clérac R, Buth G, Sougrati MT, Grandjean F, Long GJ, Anson CE, Powell AK. Magnetic and 57Fe Mössbauer study of the single molecule magnet behavior of a Dy3Fe7 coordination cluster. Inorg Chem. 2009 Oct 05;48(19):9345-55. doi: 10.1021/ic901248r. PMID: 19711941.
Copy Download .nbib Format: NLM
3-Hydr-oxy-1,2,3,9-tetra-hydro-pyrrolo[2,1-b]quinazolin-4-ium chloride dihydrate: (+)-vasicinol hydro-chloride dihydrate from Peganum harmala L.

Acta crystallographica. Section E, Structure reports online

Khan AM, Abbas G, Qureshi RA, Khan U, Ghufran MA, Stoeckli-Evans H.
PMID: 21582144
Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 06;65:o474-5. doi: 10.1107/S1600536809003766.

The title compound, C(11)H(13)N(2)O(+)·Cl(-)·2H(2)O, the dihydrate of (+)-vasicinol hydro-chloride, is a pyrrolidinoquinazoline alkaloid. It was isolated from the ethyl acetate fraction of the leaves of Peganum harmala L. The pyrrolidine ring has an envelope conformation with the C atom...

Cite
Khan AM, Abbas G, Qureshi RA, et al. 3-Hydr-oxy-1,2,3,9-tetra-hydro-pyrrolo[2,1-b]quinazolin-4-ium chloride dihydrate: (+)-vasicinol hydro-chloride dihydrate from Peganum harmala L. Acta Crystallogr Sect E Struct Rep Online. 2009;65:o474-5doi: 10.1107/S1600536809003766.
Khan, A. M., Abbas, G., Qureshi, R. A., Khan, U., Ghufran, M. A., & Stoeckli-Evans, H. (2009). 3-Hydr-oxy-1,2,3,9-tetra-hydro-pyrrolo[2,1-b]quinazolin-4-ium chloride dihydrate: (+)-vasicinol hydro-chloride dihydrate from Peganum harmala L. Acta crystallographica. Section E, Structure reports online, 65o474-5. https://doi.org/10.1107/S1600536809003766
Khan, Amir Muhammad, et al. "3-Hydr-oxy-1,2,3,9-tetra-hydro-pyrrolo[2,1-b]quinazolin-4-ium chloride dihydrate: (+)-vasicinol hydro-chloride dihydrate from Peganum harmala L." Acta crystallographica. Section E, Structure reports online vol. 65 (2009): o474-5. doi: https://doi.org/10.1107/S1600536809003766
Khan AM, Abbas G, Qureshi RA, Khan U, Ghufran MA, Stoeckli-Evans H. 3-Hydr-oxy-1,2,3,9-tetra-hydro-pyrrolo[2,1-b]quinazolin-4-ium chloride dihydrate: (+)-vasicinol hydro-chloride dihydrate from Peganum harmala L. Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 06;65:o474-5. doi: 10.1107/S1600536809003766. PMID: 21582144; PMCID: PMC2968537.
Copy Download .nbib Format: NLM
A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review.

Case reports in gastrointestinal medicine

Hakyemez IN, Sit M, Aktas G, Tas T, Mengeloglu FZ, Kucukbayrak A.
PMID: 23198187
Case Rep Gastrointest Med. 2012;2012:591561. doi: 10.1155/2012/591561. Epub 2012 Nov 11.

Hydatid cyst disease is a common worldwide zoonosis. Most of the cysts are located in the liver. Abscess formation due to infection of the cyst is an important complication. M. morganii, a Gram-negative Bacillus, is a quite rare cause...

Cite
Hakyemez IN, Sit M, Aktas G, et al. A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case Rep Gastrointest Med. 2012;2012:591561doi: 10.1155/2012/591561.
Hakyemez, I. N., Sit, M., Aktas, G., Tas, T., Mengeloglu, F. Z., & Kucukbayrak, A. (2012). A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case reports in gastrointestinal medicine, 2012591561. https://doi.org/10.1155/2012/591561
Hakyemez, Ismail Necati, et al. "A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review." Case reports in gastrointestinal medicine vol. 2012 (2012): 591561. doi: https://doi.org/10.1155/2012/591561
Hakyemez IN, Sit M, Aktas G, Tas T, Mengeloglu FZ, Kucukbayrak A. A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review. Case Rep Gastrointest Med. 2012;2012:591561. doi: 10.1155/2012/591561. Epub 2012 Nov 11. PMID: 23198187; PMCID: PMC3502769.
Copy Download .nbib Format: NLM
Reconstruction of large lateral facial defects utilizing variations of the cervicopectoral rotation flap.

The Ochsner journal

Anand AG, Amedee RG, Butcher RB.
PMID: 21603500
Ochsner J. 2008;8(4):186-90.

Large lateral facial defects as a result of trauma or head and neck oncologic surgery can present a challenging reconstructive dilemma for the operating surgeon. A number of options currently exist for reconstructing such defects, including skin grafts, myocutaneous...

Cite
Anand AG, Amedee RG, Butcher RB. Reconstruction of large lateral facial defects utilizing variations of the cervicopectoral rotation flap. Ochsner J. 2008;8(4):186-90
Anand, A. G., Amedee, R. G., & Butcher, R. B. (2008). Reconstruction of large lateral facial defects utilizing variations of the cervicopectoral rotation flap. The Ochsner journal, 8(4), 186-90.
Anand, Akash G, et al. "Reconstruction of large lateral facial defects utilizing variations of the cervicopectoral rotation flap." The Ochsner journal vol. 8,4 (2008): 186-90.
Anand AG, Amedee RG, Butcher RB. Reconstruction of large lateral facial defects utilizing variations of the cervicopectoral rotation flap. Ochsner J. 2008;8(4):186-90. PMID: 21603500; PMCID: PMC3096375.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 349 entries